RVMD
Price
$78.92
Change
+$0.41 (+0.52%)
Updated
Dec 12 closing price
Capitalization
15.26B
79 days until earnings call
Intraday BUY SELL Signals
URGN
Price
$21.80
Change
-$0.56 (-2.50%)
Updated
Dec 12 closing price
Capitalization
1.02B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RVMD vs URGN

Header iconRVMD vs URGN Comparison
Open Charts RVMD vs URGNBanner chart's image
Revolution Medicines
Price$78.92
Change+$0.41 (+0.52%)
Volume$2.24M
Capitalization15.26B
UroGen Pharma
Price$21.80
Change-$0.56 (-2.50%)
Volume$1.06M
Capitalization1.02B
RVMD vs URGN Comparison Chart in %
RVMD
Daily Signal:
Gain/Loss:
URGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 114.69B. VRTX holds the highest valuation in this group at 114.69B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 65%. NBY experienced the highest price growth at 158%, while BPTSY experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 80
Price Growth Rating: 54
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)

Market Cap

The average market capitalization across the group is 8.11B. The market cap for tickers in the group ranges from 1.05B to 15.18B. RVMD holds the highest valuation in this group at 15.18B. The lowest valued company is URGN at 1.05B.

High and low price notable news

The average weekly price growth across all stocks in the group was -4%. For the same group, the average monthly price growth was 9%, and the average quarterly price growth was 90%. RVMD experienced the highest price growth at 0%, while URGN experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the group was 16%. For the same stocks of the group, the average monthly volume growth was 5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 77
P/E Growth Rating: 100
Price Growth Rating: 37
SMR Rating: 98
Profit Risk Rating: 73
Seasonality Score: -25 (-100 ... +100)
VS
RVMD vs. URGN commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVMD is a Buy and URGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (RVMD: $78.51 vs. URGN: $22.36)
Brand notoriety: RVMD and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVMD: 89% vs. URGN: 89%
Market capitalization -- RVMD: $15.26B vs. URGN: $1.02B
RVMD [@Biotechnology] is valued at $15.26B. URGN’s [@Biotechnology] market capitalization is $1.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVMD’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • RVMD’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, RVMD is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVMD’s TA Score shows that 2 TA indicator(s) are bullish while URGN’s TA Score has 3 bullish TA indicator(s).

  • RVMD’s TA Score: 2 bullish, 5 bearish.
  • URGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, URGN is a better buy in the short-term than RVMD.

Price Growth

RVMD (@Biotechnology) experienced а +0.04% price change this week, while URGN (@Biotechnology) price change was -7.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

RVMD is expected to report earnings on Mar 02, 2026.

URGN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($15.3B) has a higher market cap than URGN($1.02B). URGN YTD gains are higher at: 109.953 vs. RVMD (79.492). URGN has higher annual earnings (EBITDA): -144.14M vs. RVMD (-1.02B). RVMD has more cash in the bank: 1.93B vs. URGN (127M). URGN has less debt than RVMD: URGN (128M) vs RVMD (158M). URGN has higher revenues than RVMD: URGN (96.5M) vs RVMD (0).
RVMDURGNRVMD / URGN
Capitalization15.3B1.02B1,500%
EBITDA-1.02B-144.14M710%
Gain YTD79.492109.95372%
P/E RatioN/AN/A-
Revenue096.5M-
Total Cash1.93B127M1,521%
Total Debt158M128M123%
FUNDAMENTALS RATINGS
RVMD vs URGN: Fundamental Ratings
RVMD
URGN
OUTLOOK RATING
1..100
3170
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
47100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3639
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

URGN's Valuation (59) in the Biotechnology industry is somewhat better than the same rating for RVMD (96) in the null industry. This means that URGN’s stock grew somewhat faster than RVMD’s over the last 12 months.

RVMD's Profit vs Risk Rating (47) in the null industry is somewhat better than the same rating for URGN (100) in the Biotechnology industry. This means that RVMD’s stock grew somewhat faster than URGN’s over the last 12 months.

RVMD's SMR Rating (96) in the null industry is in the same range as URGN (100) in the Biotechnology industry. This means that RVMD’s stock grew similarly to URGN’s over the last 12 months.

RVMD's Price Growth Rating (36) in the null industry is in the same range as URGN (39) in the Biotechnology industry. This means that RVMD’s stock grew similarly to URGN’s over the last 12 months.

RVMD's P/E Growth Rating (100) in the null industry is in the same range as URGN (100) in the Biotechnology industry. This means that RVMD’s stock grew similarly to URGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVMDURGN
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 24 days ago
76%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
RVMD
Daily Signal:
Gain/Loss:
URGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDIV27.500.20
+0.72%
MarketDesk Focused U.S. Dividend ETF
FTCE25.100.13
+0.51%
First Trust New Cstrcts Cr Erns Ldrs ETF
BNDW69.45N/A
N/A
Vanguard Total World Bond ETF
IBHK25.91N/A
N/A
iShares iBonds 2031 Ter Hi Yld AndIncETF
STOT47.31-0.01
-0.02%
State Street®DoubleLine®ShrtDurTRTactETF

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+0.81%
NUVL - RVMD
61%
Loosely correlated
+0.16%
CGON - RVMD
56%
Loosely correlated
-0.31%
IDYA - RVMD
54%
Loosely correlated
-0.24%
CLDX - RVMD
54%
Loosely correlated
-0.89%
IRON - RVMD
54%
Loosely correlated
+0.81%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with AIM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+0.77%
AIM - URGN
39%
Loosely correlated
N/A
CYYNF - URGN
38%
Loosely correlated
N/A
PHAT - URGN
37%
Loosely correlated
+0.14%
RVMD - URGN
36%
Loosely correlated
+0.81%
CVAC - URGN
34%
Loosely correlated
+0.20%
More